Lepu Biopharma Co., Ltd.

Informe acción SEHK:2157

Capitalización de mercado: HK$5.3b

Lepu Biopharma Dirección

Dirección controles de criterios 3/4

We currently do not have sufficient information about the CEO.

Información clave

Ziye Sui

Chief Executive Officer (CEO)

CN¥8.8m

Compensación total

Porcentaje del salario del CEO22.1%
Permanencia del CEOless than a year
Participación del CEOn/a
Permanencia media de la dirección3.6yrs
Promedio de permanencia en la Junta Directiva3.9yrs

Actualizaciones recientes de la dirección

Recent updates

Lepu Biopharma (HKG:2157) Is Making Moderate Use Of Debt

Aug 23
Lepu Biopharma (HKG:2157) Is Making Moderate Use Of Debt

The Price Is Right For Lepu Biopharma Co., Ltd. (HKG:2157) Even After Diving 27%

Jul 18
The Price Is Right For Lepu Biopharma Co., Ltd. (HKG:2157) Even After Diving 27%

Lepu Biopharma Co., Ltd. (HKG:2157) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

Jun 03
Lepu Biopharma Co., Ltd. (HKG:2157) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

Revenues Not Telling The Story For Lepu Biopharma Co., Ltd. (HKG:2157) After Shares Rise 26%

Apr 15
Revenues Not Telling The Story For Lepu Biopharma Co., Ltd. (HKG:2157) After Shares Rise 26%

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Ziye Sui en comparación con los beneficios de Lepu Biopharma?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2024n/an/a

-CN¥73m

Mar 31 2024n/an/a

-CN¥47m

Dec 31 2023CN¥9mCN¥2m

-CN¥22m

Sep 30 2023n/an/a

-CN¥254m

Jun 30 2023n/an/a

-CN¥487m

Mar 31 2023n/an/a

-CN¥588m

Dec 31 2022CN¥9mCN¥2m

-CN¥689m

Sep 30 2022n/an/a

-CN¥766m

Jun 30 2022n/an/a

-CN¥843m

Mar 31 2022n/an/a

-CN¥927m

Dec 31 2021CN¥12mCN¥2m

-CN¥1b

Dec 31 2020CN¥2mCN¥1m

-CN¥582m

Compensación vs. Mercado: Ziye's total compensation ($USD1.24M) is above average for companies of similar size in the Hong Kong market ($USD495.13K).

Compensación vs. Ingresos: Ziye's compensation has been consistent with company performance over the past year.

CEO

Ziye Sui (43 yo)

less than a year

Permanencia

CN¥8,789,000

Compensación

Dr. Ziye Sui, M.D. Ph.D. had been Non-Executive Director of Star Combo Pharma Ltd since June 21, 2018 until August 24, 2022. She is the Vice President of Lepu Medical Technology (Beijing) Co. Limited. She...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Zhongjie Pu
Executive Chairman6.8yrssin datos25.33%
HK$ 1.3b
Ziye Sui
CEO & Directorless than a yearCN¥8.79msin datos
Yunyi Li
CFO & Board Secretary3.9yrssin datossin datos
Minmin Qin
Chief Technology Officer3.9yrssin datossin datos
Lixuan Zhao
Supervisor & Investor Relations Director1.7yrssin datossin datos
Siu Kuen Lai
Joint Company Secretary3.6yrssin datossin datos

3.6yrs

Permanencia media

46yo

Promedio de edad

Equipo directivo experimentado: 2157's management team is considered experienced (3.6 years average tenure).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Zhongjie Pu
Executive Chairman6.8yrssin datos25.33%
HK$ 1.3b
Ziye Sui
CEO & Director4.6yrsCN¥8.79msin datos
Lixuan Zhao
Supervisor & Investor Relations Directorless than a yearsin datossin datos
Fengmao Hua
Independent Non-Executive Director2.9yrsCN¥250.00ksin datos
Yang Xu
Supervisor3.9yrssin datossin datos
Haifeng Yang
Independent Non-Executive Director3.9yrsCN¥250.00ksin datos
Hongbing Yang
Non-Executive Director4.6yrssin datossin datos
Jue Pu
Non-Executive Director4.6yrssin datos5.26%
HK$ 276.3m
Demin Zhou
Independent Non-Executive Director3.9yrsCN¥250.00ksin datos
Ming Yang
Supervisor3.9yrssin datossin datos

3.9yrs

Permanencia media

54.5yo

Promedio de edad

Junta con experiencia: 2157's board of directors are considered experienced (3.9 years average tenure).